|
|
Volumn 17, Issue SUPPL. E, 1996, Pages 21-27
|
|
Thrombolytic therapy in Europe: Current status
a
a
HÔPITAL TENON
(France)
|
|
Author keywords
Acute myocardial infarction; Anistreplase; Open artery theory; PTCA; Streptokinase; Thrombolytics; Tissue plasminogen activator
|
|
Indexed keywords
ALTEPLASE;
ANISTREPLASE;
FIBRINOLYTIC AGENT;
HEPARIN;
STAPHYLOKINASE;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
UROKINASE;
ACUTE HEART INFARCTION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORONARY ARTERY BYPASS GRAFT;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
EMERGENCY MEDICINE;
EUROPE;
FIBRINOLYTIC THERAPY;
GENERAL PRACTITIONER;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE INJURY;
HOME;
HOSPITAL ADMISSION;
HUMAN;
HYPOTENSION;
INTRAVENOUS DRUG ADMINISTRATION;
MEDICAL PERSONNEL;
META ANALYSIS;
MORTALITY;
NONHUMAN;
PATIENT CARE;
PRIORITY JOURNAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
SURVIVAL;
SYMPTOM;
TRANSLUMINAL CORONARY ANGIOPLASTY;
|
|
EID: 0029846490
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1093/eurheartj/17.suppl_e.21 Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (0)
|
